$337 Million is the total value of Capital Impact Advisors, LLC's 109 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARWR | ARROWHEAD PHARMACEUTICALS IN | $7,673,000 | -0.3% | 178,183 | 0.0% | 2.27% | -11.5% | |
| EPAM | EPAM SYS INC | $3,540,000 | +28.3% | 10,949 | 0.0% | 1.05% | +13.9% | |
| CRM | SALESFORCE COM INC | $3,518,000 | +34.1% | 14,000 | 0.0% | 1.04% | +19.1% | |
| VRSN | VERISIGN INC | $3,321,000 | -1.0% | 16,212 | 0.0% | 0.98% | -12.1% | |
| WDAY | WORKDAY INCcl a | $3,119,000 | +14.8% | 14,500 | 0.0% | 0.92% | +1.9% | |
| CORT | CORCEPT THERAPEUTICS INC | $3,086,000 | +3.5% | 177,300 | 0.0% | 0.92% | -8.1% | |
| BLK | BLACKROCK INC | $3,066,000 | +3.6% | 5,440 | 0.0% | 0.91% | -8.1% | |
| VICR | VICOR CORP | $3,053,000 | +8.0% | 39,282 | 0.0% | 0.90% | -4.1% | |
| ADBE | ADOBE SYSTEMS INCORPORATED | $3,026,000 | +12.7% | 6,171 | 0.0% | 0.90% | 0.0% | |
| IONS | IONIS PHARMACEUTICALS INC | $3,023,000 | -19.5% | 63,707 | 0.0% | 0.90% | -28.5% | |
| MDB | MONGODB INCcl a | $3,019,000 | +2.3% | 13,042 | 0.0% | 0.90% | -9.2% | |
| RMD | RESMED INC | $2,764,000 | -10.7% | 16,125 | 0.0% | 0.82% | -20.8% | |
| SMCI | SUPER MICRO COMPUTER INC | $2,660,000 | -7.0% | 100,761 | 0.0% | 0.79% | -17.6% | |
| OMCL | OMNICELL COM | $2,534,000 | +5.7% | 33,938 | 0.0% | 0.75% | -6.2% | |
| CLH | CLEAN HARBORS INC | $2,351,000 | -6.6% | 41,966 | 0.0% | 0.70% | -17.1% | |
| VEEV | VEEVA SYS INC | $2,330,000 | +20.0% | 8,285 | 0.0% | 0.69% | +6.5% | |
| FLT | FLEETCOR TECHNOLOGIES INC | $2,300,000 | -5.3% | 9,660 | 0.0% | 0.68% | -16.0% | |
| UTHR | UNITED THERAPEUTICS CORP DEL | $2,228,000 | -16.5% | 22,058 | 0.0% | 0.66% | -25.9% | |
| AVLR | AVALARA INC | $2,168,000 | -4.3% | 17,026 | 0.0% | 0.64% | -15.2% | |
| NBIX | NEUROCRINE BIOSCIENCES INC | $2,126,000 | -21.2% | 22,106 | 0.0% | 0.63% | -30.1% | |
| LMAT | LEMAITRE VASCULAR INC | $2,120,000 | +23.2% | 65,173 | 0.0% | 0.63% | +9.2% | |
| INTU | INTUIT | $2,074,000 | +10.1% | 6,359 | 0.0% | 0.62% | -2.2% | |
| MEDP | MEDPACE HLDGS INC | $1,978,000 | +20.2% | 17,698 | 0.0% | 0.59% | +6.5% | |
| KURA | KURA ONCOLOGY INC | $1,910,000 | +88.0% | 62,331 | 0.0% | 0.57% | +67.0% | |
| MPW | MEDICAL PPTYS TRUST INC | $1,762,000 | -6.2% | 99,957 | 0.0% | 0.52% | -16.9% | |
| SUPN | SUPERNUS PHARMACEUTICALS INC | $1,743,000 | -12.2% | 83,632 | 0.0% | 0.52% | -22.0% | |
| EGRX | EAGLE PHARMACEUTICALS INC | $1,521,000 | -11.5% | 35,815 | 0.0% | 0.45% | -21.4% | |
| MPWR | MONOLITHIC PWR SYS INC | $1,449,000 | +18.0% | 5,182 | 0.0% | 0.43% | +4.6% | |
| MMSI | MERIT MED SYS INC | $1,388,000 | -4.7% | 31,915 | 0.0% | 0.41% | -15.6% | |
| PNFP | PINNACLE FINL PARTNERS INC | $996,000 | -15.2% | 27,994 | 0.0% | 0.30% | -24.7% | |
| HSTM | HEALTHSTREAM INC | $939,000 | -9.3% | 46,764 | 0.0% | 0.28% | -19.7% | |
| NRC | NATIONAL RESH CORP | $685,000 | -15.4% | 13,917 | 0.0% | 0.20% | -25.1% | |
| CPRX | CATALYST PHARMACEUTICALS INC | $603,000 | -35.7% | 203,133 | 0.0% | 0.18% | -42.8% | |
| TTEC | TTEC HLDGS INC | $584,000 | +17.3% | 10,700 | 0.0% | 0.17% | +4.2% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS CORP DEL | 38 | Q2 2023 | 3.1% |
| AMERESCO INC | 38 | Q3 2023 | 1.7% |
| REGENERON PHARMACEUTICALS | 37 | Q4 2022 | 2.7% |
| HEALTHSTREAM INC | 37 | Q2 2023 | 0.9% |
| INSPERITY INC | 36 | Q2 2023 | 1.6% |
| META PLATFORMS INC | 35 | Q4 2022 | 3.8% |
| STEEL DYNAMICS INC | 34 | Q4 2022 | 3.1% |
| SHUTTERSTOCK INC | 34 | Q3 2023 | 1.2% |
| INTERCONTINENTAL EXCHANGE IN | 33 | Q4 2022 | 1.8% |
| CLEAN HARBORS INC | 33 | Q3 2023 | 2.4% |
View Capital Impact Advisors, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-15 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-23 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2022-11-22 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Capital Impact Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.